Lacerca-Allen, chief compliance officer (CCO) at Cipla USA, then paralleled sports with business. Redefining the CCO roleLacerca-Allen recently penned an article with Dolores Guzmán, appearing in the International In-house Counsel Journal, titled “Crisis-Capable Compliance: The CCO at the Crossroads of AI, Ethics, and Leadership.” In it, they tackled a familiar question posed at recent pharmaceutical compliance events—what is expected of the CCO role today? Lacerca-Allen and Guzmán offer specific actions to build accountability back into the organization, steps that CCOs can take toward “crisis-capable compliance.” “As the world is changing, accountability is changing,” Lacerca-Allen told BioXconomy.